PriceTargets.com logo

Plains GP - PAGP Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $19.88
  • Forecasted Upside: 5.66%
  • Number of Analysts: 9
  • Breakdown:
  • 2 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$18.81 As of 11/20/2024 01:00 AM ET
▲ +0.24 (1.29%)

This chart shows the closing price for PAGP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Plains GP Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PAGP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PAGP

Analyst Price Target is $19.88
▲ +5.66% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Plains GP in the last 3 months. The average price target is $19.88, with a high forecast of $23.00 and a low forecast of $16.00. The average price target represents a 5.66% upside from the last price of $18.81.

This chart shows the closing price for PAGP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 9 polled investment analysts is to hold stock in Plains GP. This rating has held steady since June 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
5/31/2023
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/29/2023
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
11/27/2023
  • 1 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
2/25/2024
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
5/25/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
8/23/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
10/22/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
11/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/25/2024Morgan StanleyDowngradeOverweight ➝ Equal Weight$22.00 ➝ $19.00
9/18/2024Wolfe ResearchUpgradeHold
6/10/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$19.00 ➝ $20.00
5/8/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$19.00 ➝ $20.00
5/6/2024CitigroupBoost TargetNeutral ➝ Neutral$17.50 ➝ $18.00
4/16/2024Stifel NicolausBoost TargetBuy ➝ Buy$18.00 ➝ $22.00
4/12/2024UBS GroupBoost TargetBuy ➝ Buy$22.00 ➝ $23.00
4/12/2024The Goldman Sachs GroupBoost TargetSell ➝ Sell$14.50 ➝ $16.00
4/12/2024BarclaysBoost TargetUnderweight ➝ Underweight$16.00 ➝ $18.00
4/8/2024ScotiabankInitiated CoverageSector Outperform$23.00
3/1/2024CitigroupBoost TargetNeutral ➝ Neutral$16.50 ➝ $17.50
11/6/2023Truist FinancialBoost TargetBuy ➝ Buy$17.00 ➝ $21.00
10/5/2023The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$13.50
9/25/2023BarclaysDowngradeEqual Weight ➝ Underweight$15.00
9/6/2023CitigroupDowngradeBuy ➝ Neutral$14.00 ➝ $15.50
7/21/2023Raymond JamesBoost TargetStrong-Buy$17.00 ➝ $18.00
7/20/2023Morgan StanleyBoost TargetOverweight$17.00 ➝ $18.00
7/12/2023MizuhoBoost Target$17.00 ➝ $19.00
4/25/2023Morgan StanleyBoost Target$16.00 ➝ $17.00
4/21/2023Raymond JamesUpgradeOutperform ➝ Strong-Buy$16.00 ➝ $17.00
4/18/2023BarclaysBoost Target$13.00 ➝ $15.00
3/9/2023JPMorgan Chase & Co.Boost TargetNeutral$14.00 ➝ $15.00
2/23/2023UBS GroupBoost TargetBuy$19.00 ➝ $20.00
2/9/2023Raymond JamesBoost TargetOutperform$13.00 ➝ $16.00
2/1/2023MizuhoBoost TargetBuy$15.00 ➝ $17.00
12/8/2022CitigroupInitiated CoverageBuy$14.00
12/2/2022Truist FinancialBoost TargetBuy$14.00 ➝ $15.00
11/21/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$15.00 ➝ $14.00
11/8/2022MizuhoBoost TargetBuy$13.00 ➝ $15.00
11/4/2022Wells Fargo & CompanyLower TargetOverweight$16.00 ➝ $15.00
10/20/2022Morgan StanleyBoost TargetOverweight$15.00 ➝ $16.00
8/16/2022BarclaysBoost TargetEqual Weight$12.00 ➝ $13.00
8/14/2022Stifel NicolausUpgradeHold ➝ Buy$14.00 ➝ $16.00
8/4/2022UBS GroupBoost TargetBuy$17.00 ➝ $18.00
8/1/2022Wolfe ResearchDowngradeOutperform ➝ Market Perform
7/20/2022BarclaysLower TargetEqual Weight$13.00 ➝ $12.00
7/19/2022Bank of AmericaUpgradeUnderperform ➝ Neutral$12.00
7/8/2022UBS GroupBoost TargetBuy$16.00 ➝ $17.00
5/12/2022Credit Suisse GroupUpgradeNeutral ➝ Outperform$13.00 ➝ $14.00
4/26/2022Morgan StanleyBoost TargetOverweight$14.00 ➝ $15.00
4/20/2022Raymond JamesBoost TargetOutperform$12.00 ➝ $13.00
2/11/2022Raymond JamesLower TargetOutperform$13.00 ➝ $12.00
1/25/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$14.50
1/24/2022Raymond JamesBoost TargetOutperform$12.00 ➝ $13.00
1/20/2022BarclaysBoost Target$12.00 ➝ $13.00
1/18/2022Bank of AmericaBoost TargetUnderperform$10.50 ➝ $11.00
1/10/2022Wolfe ResearchUpgradePeer Perform ➝ Outperform
12/16/2021Wells Fargo & CompanyBoost TargetOverweight$14.00 ➝ $15.00
11/29/2021BarclaysInitiated CoverageEqual Weight
10/28/2021Seaport Res PtnDowngradeBuy ➝ Neutral
9/28/2021Bank of AmericaInitiated CoverageUnderperform
7/21/2021Raymond JamesBoost TargetOutperform$10.00 ➝ $12.00
7/16/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$13.00
7/13/2021CitigroupBoost TargetBuy$11.00 ➝ $13.00
6/24/2021Wells Fargo & CompanyBoost TargetOverweight$12.00 ➝ $14.00
6/18/2021Morgan StanleyBoost TargetEqual Weight$12.00 ➝ $13.00
5/26/2021Morgan StanleyBoost TargetEqual Weight$11.00 ➝ $12.00
3/29/2021Morgan StanleyReiterated RatingOverweight ➝ Equal Weight
3/22/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight
3/19/2021BarclaysLower TargetEqual Weight$12.00 ➝ $11.00
3/17/2021Wolfe ResearchReiterated RatingOutperform ➝ Peer Perform
3/11/2021Wolfe ResearchDowngradeOutperform ➝ Peer Perform
2/11/2021Morgan StanleyLower TargetOverweight$12.00 ➝ $11.00
2/1/2021ScotiabankInitiated CoverageOutperform
1/20/2021MizuhoBoost TargetBuy$13.00 ➝ $14.00
1/14/2021Raymond JamesBoost TargetOutperform$9.00 ➝ $12.00
12/11/2020Morgan StanleyBoost TargetOverweight$8.00 ➝ $12.00
10/20/2020Raymond JamesLower TargetOutperform$11.00 ➝ $9.00
9/25/2020Morgan StanleyUpgradeUnderweight ➝ Overweight
8/21/2020Morgan StanleyBoost TargetUnderweight$7.00 ➝ $8.00
7/21/2020Raymond JamesBoost TargetOutperform$10.00 ➝ $11.00
7/21/2020Bank of AmericaUpgradeUnderperform ➝ Buy
6/1/2020Morgan StanleyBoost TargetUnderweight$6.00 ➝ $7.00
5/18/2020Bank of AmericaDowngradeNeutral ➝ Underperform
5/14/2020JPMorgan Chase & Co.Lower TargetOverweight$14.00 ➝ $12.00
4/22/2020SunTrust BanksLower TargetBuy$14.00 ➝ $12.00
4/14/2020Wells Fargo & CompanyLower TargetOverweight$15.00 ➝ $13.00
4/8/2020Morgan StanleyBoost TargetUnderweight$5.00 ➝ $6.00
4/2/2020Credit Suisse GroupDowngradeOutperform ➝ Neutral$8.00
3/24/2020BarclaysDowngradeOverweight ➝ Equal Weight$8.00
3/16/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight
3/12/2020Stifel NicolausDowngradeBuy ➝ Hold
3/12/2020Raymond JamesDowngradeStrong-Buy ➝ Outperform$25.00 ➝ $14.00
3/11/2020Bank of AmericaDowngradeBuy ➝ Neutral
3/9/2020Robert W. BairdDowngradeOutperform ➝ Neutral$21.00 ➝ $12.00
2/6/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$19.00
1/14/2020BarclaysUpgradeEqual Weight ➝ Overweight$24.00
1/6/2020Morgan StanleyInitiated CoverageEqual Weight$19.00
12/9/2019The Goldman Sachs GroupInitiated CoverageNeutral$18.00
12/2/2019Robert W. BairdUpgradeNeutral ➝ Outperform$22.00 ➝ $21.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.90 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 5 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
5/24/2024
  • 9 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 9 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 7 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 12 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 12 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 12 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Plains GP logo
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks. It engages in the loading and unloading services at terminals; NGL fractionation and isomerization services; and natural gas and condensate processing services. The company offers logistics services to producers, refiners, and other customers. PAA GP Holdings LLC operates as a general partner of the company. Plains GP Holdings, L.P. was incorporated in 2013 and is headquartered in Houston, Texas.
Read More

Today's Range

Now: $18.81
Low: $18.61
High: $18.85

50 Day Range

MA: $18.44
Low: $17.20
High: $19.23

52 Week Range

Now: $18.81
Low: $14.93
High: $20.10

Volume

1,338,794 shs

Average Volume

1,826,946 shs

Market Capitalization

$3.71 billion

P/E Ratio

22.13

Dividend Yield

6.84%

Beta

1.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Plains GP?

The following Wall Street research analysts have issued research reports on Plains GP in the last year: Barclays PLC, Citigroup Inc., Morgan Stanley, Scotiabank, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for PAGP.

What is the current price target for Plains GP?

0 Wall Street analysts have set twelve-month price targets for Plains GP in the last year. Their average twelve-month price target is $19.88, suggesting a possible upside of 5.7%. UBS Group AG has the highest price target set, predicting PAGP will reach $23.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $16.00 for Plains GP in the next year.
View the latest price targets for PAGP.

What is the current consensus analyst rating for Plains GP?

Plains GP currently has 2 sell ratings, 3 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PAGP, but not buy more shares or sell existing shares.
View the latest ratings for PAGP.

What other companies compete with Plains GP?

Other companies that are similar to Plains GP include Plains All American Pipeline, HF Sinclair, Delek Logistics Partners, Genesis Energy and Enbridge. Learn More about companies similar to Plains GP.

How do I contact Plains GP's investor relations team?

Plains GP's physical mailing address is 333 CLAY STREET SUITE 1600, HOUSTON TX, 77002. The pipeline company's listed phone number is (703) 646-4100 and its investor relations email address is [email protected]. The official website for Plains GP is www.plainsallamerican.com. Learn More about contacing Plains GP investor relations.